Humana ABLTS:0RF7 +0.63%58 Days Payable is 0.00 as of Mar. 2026. GuruFocus rates LTS:0RF7 with a GF Score™ of 58/100 and a GF Value™ of kr36.23 (Significantly Overvalued). The stock has 6 warning signs investors should review. Among 606 Healthcare Providers & Services companies, Humana AB ranks worse than 165016.34% on this metric.
The historical rank and industry rank for Humana AB's Days Payable or its related term are showing as below:
During the past 13 years, Humana AB's highest Days Payable was 198.64. The lowest was 99.45. And the median was 132.40.
LTS:0RF7's Days Payable is not ranked *
in the Healthcare Providers & Services industry.
Industry Median: 58.205 * Ranked among companies with meaningful Days Payable only.
Humana AB's Days Payable
stayed the same
from Mar. 2025 (0.00) to Mar. 2026 (0.00).
stayed the same
Humana AB Days Payable Related Terms
Humana AB Days Payable Historical Data
* Premium members only.
The historical data trend for Humana AB's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
LTS:0RF7 vs HCA, THC, DVA: Days Payable Comparison
For the Medical Care Facilities subindustry, Humana AB's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Humana AB Days Payable vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Humana AB's Days Payable distribution charts can be found below:
* The bar in red indicates where Humana AB's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Humana AB's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Humana AB (LTS:0RF7) has a Days Payable of 0.00 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Humana AB and its competitors. Over the past decade, Humana AB's Days Payable has ranged from 99.45 to 198.64. According to the industry distribution chart, Humana AB ranks #999999 out of 606 companies in the Healthcare Providers & Services industry.
Is Humana AB's Days Payable too high?
Humana AB's current Days Payable is 0.00. Over the past 10 years, this metric has ranged from a low of 99.45 to a high of 198.64. Based on the distribution chart, Humana AB ranks #999999 out of 606 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Humana AB has a GF Score™ of 58/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Humana AB's Days Payable compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Humana AB ranks #999999 out of 606 companies for Days Payable. This places Humana AB in the lower half of its industry. The industry median Days Payable is 58.21. Historically, Humana AB's own Days Payable has ranged from 99.45 to 198.64 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Healthcare Providers & Services company?
The median Days Payable among Healthcare Providers & Services companies is 58.21, based on 606 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Humana AB and its competitors. For the Healthcare Providers & Services industry, the median Days Payable is 58.21 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Humana AB's current Days Payable is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Humana AB stock overvalued right now?
Based on GuruFocus' analysis, Humana AB (LTS:0RF7) is currently considered Significantly Overvalued. The stock's GF Value™ is kr36.23, compared to a current price of kr63.45 — trading 75.1% above its estimated fair value. The current Days Payable is 0.00. Humana AB's overall GF Score™ is 58/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Humana AB (LTS:0RF7), the current Days Payable is 0.00 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Humana AB (LTS:0RF7) Overvalued in 2026?
Based on GuruFocus' analysis, Humana AB stock appears to be overvalued.
The current stock price of kr63.45 is trading 75.1% above its estimated GF Value™ of kr36.23.
GuruFocus considers Humana AB to be Significantly Overvalued.
Key valuation signals for LTS:0RF7:
Days Payable: 0.00
GF Value™: kr36.23 vs. price of kr63.45 (75.1% above fair value)
No single metric tells the full story. See the LTS:0RF7 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Humana AB is a provider of private care services in the Nordic region. The company offers services including individual and family care, personal assistance, elderly care and housing with special services. Geographically, the company operates in Sweden, Norway, Finland, Denmark, and others. It derives maximum revenue from Sweden.
58GF Score
Get the complete analysis for LTS:0RF7
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LTS:0RF7 has been successfully added to your 
